NeuroBrave Ltd.

Founded in 2019 and headquartered in Jerusalem, Israel, NeuroBrave Ltd. specializes in advanced neurotechnology solutions, enhancing data utilization for various industries with innovative products like NeuroSpeed OS™. NeuroBrave Ltd. offers advanced neurotechnology solutions, focusing on optimizing sensory data across multiple sectors.

Founded in 2019, the company is based in Jerusalem, Israel. It was established through the efforts of its founder, whose detailed history is not provided. The company has completed a total of 1 deal, with the most recent funding round occurring on May 27, 2021, when it raised venture funding from Samurai Incubate. NeuroBrave specializes in advanced neurotechnology solutions, with its flagship product being NeuroSpeed OS™, a data-driven deep neural network (DNN) platform designed to optimize sensory data utilization.

This platform integrates multiple functionalities, including sensor fusion, which enhances connectivity and facilitates new discoveries about cognitive states and performance. NeuroSpeed OS™ is aimed at a diverse range of industries such as manufacturing, where it enhances productivity by providing real-time insights, and the gaming sector, where it fosters adaptive gaming experiences tailored to individual players. Additionally, the platform offers a neuromarkers generator, enabling businesses to leverage real-time, ready-to-use neuromarkers for various applications. NeuroBrave's products are marketed primarily in North America and Europe, targeting corporate clients and sectors that prioritize innovation and efficiency in their operations.

NeuroBrave's revenue model primarily revolves around B2B transactions, where businesses engage with the company to utilize its advanced neurotechnology solutions. The company operates through a subscription-based framework for its NeuroSpeed OS™, allowing clients to access ongoing updates and support. Partnerships with various enterprises facilitate the integration of its products into existing infrastructures, enhancing overall performance and productivity. Although specific pricing details are not disclosed, the structure typically involves tiered subscription plans that accommodate different client needs and usage scales.

By providing tailored solutions and ongoing support, NeuroBrave cultivates long-term relationships with its clients, thereby contributing to a sustainable revenue stream. Following its most recent funding round in May 2021, NeuroBrave aims to enhance its product offerings, with plans for upcoming new features and improvements to NeuroSpeed OS™. The company is also targeting expansion into new geographic markets, particularly looking at opportunities in Asia and South America by the end of 2023. The funding raised will support these initiatives, helping to bolster product development and market entry efforts.